A group of researchers at Osaka University has developed a new immune cell therapy that could be applied to patients of acute ...

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 ...

First quarter 2025 total revenue of approximately $53.3 million, which includes net product sales of $43.6 million and contract revenues from collaborations of $9.8 ...

U-32 HIGH SCHOOL HOSTED ITS YEARLY BLOOD DRIVE WITH 65 PEOPLE SIGNING ABOUT TO DONATE.... THE AMERICAN RED CROSS SAYS IN VERMONT ALONE ROUGHLY 80 UNITS OF BLOOD ARE NEEDE ...

A Texas mom shared heartwarming video of her daughter’s delight after her brother came to visit her in the hospital. Abby was ...

Phase 1 clinical data of INB-100 continues to demonstrate long-term durable remissions, with 100% of treated Acute Myeloid ...

Primary endpoint met in R/R mNPM1 AML patients in pivotal Phase 2 portion of the AUGMENT-101 trial – – Robust remission rates in heavily pre-treated R/R mNPM1 AML population with nearly 50% overall ...

A promising target for rare liver cancer, a functional cure for multiple myeloma — and support for people with ovarian cancer.

Transplantation improves survival after cladribine-based therapy for patients with relapsed/refractory acute myeloid leukemia ...

Amandeep Salhotra, MD, discusses data from the phase 3 Precision-T trial of Orca-T in patients with advanced hematologic malignancies.

On Sunday, May 18, the 2025 Northwell Walk to Raise Health will take place to raise funds for cancer care. The Staten Island event will honor Charlee Citera, an Annadale girl whose battle with ...